Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07263399

Effect of Hydrogen Gas on Hyperbaric Oxygen Toxicity

Effect of Hydrogen Gas on Hyperbaric Oxygen Toxicity - A Randomized Controlled Cross-Over Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
32 (estimated)
Sponsor
Blekinge Institute of Technology · Academic / Other
Sex
All
Age
20 Years – 64 Years
Healthy volunteers
Accepted

Summary

The goal of this trial is to investigate whether adding a small fraction of hydrogen gas to an oxygen-enriched breathing mixture can reduce pulmonary oxygen toxicity (POT) in healthy and active divers from the Swedish Armed Forces. The main questions it aims to answer are: * Does hydrogen gas reduce oxidative stress and changes in pulmonary function associated with prolonged hyperbaric oxygen exposure? * What are the underlying pathophysiological mechanisms of pulmonary oxygen toxicity? Researchers will compare oxygen-enriched breathing gas with 1-2% hydrogen to oxygen-enriched gas with 1-2% nitrogen (control) to see if hydrogen provides protective effects against POT during hyperbaric exposure. Participants will: * Complete two hyperbaric exposure sessions (hydrogen vs. nitrogen), each lasting 240 minutes at 1.75 ATA * Undergo pulmonary function tests and sampling of blod and urin before and after each session * Serve as their own controls in a double-blind, randomized, crossover study design

Conditions

Interventions

TypeNameDescription
OTHERInhaled Hydrogen-Enriched Oxygen GasParticipants will inhale a gas mixture consisting of 98-99% oxygen and 1-2% hydrogen via a breathing circuit during a single hyperbaric exposure. The exposure will be conducted at a partial pressure of 1.75 ATA for 240 minutes. The intervention aims to evaluate the protective effect of hydrogen gas against pulmonary oxygen toxicity.
OTHERInhaled Nitrogen-Enriched Oxygen GasParticipants will inhale a gas mixture consisting of 98-99% oxygen and 1-2% nitrogen via a breathing circuit during a single hyperbaric exposure. The exposure will be conducted at a partial pressure of 1.75 ATA for 240 minutes. The intervention aims to evaluate the protective effect of hydrogen gas against pulmonary oxygen toxicity.

Timeline

Start date
2026-01-01
Primary completion
2029-12-01
Completion
2030-12-01
First posted
2025-12-04
Last updated
2025-12-04

Locations

2 sites across 1 country: Sweden

Source: ClinicalTrials.gov record NCT07263399. Inclusion in this directory is not an endorsement.